RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Retension Pharmaceuticals, Inc.
$16.33+2.26 (+16.06%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Retension Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| The B Group, Inc. | 833,333 | 10.00% | 13G (passive) | Oct 13, 2026 |
| Laurence W. Lytton | 617,207 | 7.40% | 13G (passive) | Oct 13, 2026 |
| Eric Keller | 598,598 | 7.07% | 13D (active) | Oct 13, 2026 |
| Pvg Asset Management Corp | 1,002,050 | 8.30% | 13G (passive) | Oct 9, 2026 |